185 related articles for article (PubMed ID: 30427539)
1. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
Narayan RR; Creasy JM; Goldman DA; Gönen M; Kandoth C; Kundra R; Solit DB; Askan G; Klimstra DS; Basturk O; Allen PJ; Balachandran VP; D'Angelica MI; DeMatteo RP; Drebin JA; Kingham TP; Simpson AL; Abou-Alfa GK; Harding JJ; O'Reilly EM; Butte JM; Matsuyama R; Endo I; Jarnagin WR
Cancer; 2019 Feb; 125(4):575-585. PubMed ID: 30427539
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression.
Butte JM; Torres J; Veras EF; Matsuo K; Gönen M; D'Angelica MI; Waugh E; Meneses M; Inayama Y; Fong Y; Dematteo RP; De La Fuente H; Endo I; Klimstra DS; Jarnagin WR
Ann Surg Oncol; 2013 May; 20(5):1470-81. PubMed ID: 23212762
[TBL] [Abstract][Full Text] [Related]
3. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889
[TBL] [Abstract][Full Text] [Related]
4. Progression of gene hypermethylation in gallstone disease leading to gallbladder cancer.
House MG; Wistuba II; Argani P; Guo M; Schulick RD; Hruban RH; Herman JG; Maitra A
Ann Surg Oncol; 2003 Oct; 10(8):882-9. PubMed ID: 14527906
[TBL] [Abstract][Full Text] [Related]
5. Squamous variant of gallbladder cancer: is it different from adenocarcinoma?
Kalayarasan R; Javed A; Sakhuja P; Agarwal AK
Am J Surg; 2013 Sep; 206(3):380-5. PubMed ID: 23827515
[TBL] [Abstract][Full Text] [Related]
6. Squamous/adenosquamous carcinoma of the gallbladder: Analysis of 34 cases and comparison of clinicopathologic features and surgical outcomes with adenocarcinoma.
Song HW; Chen C; Shen HX; Ma L; Zhao YL; Zhang GJ; Geng ZM; Wang L
J Surg Oncol; 2015 Nov; 112(6):677-80. PubMed ID: 26458491
[TBL] [Abstract][Full Text] [Related]
7. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile.
Wistuba II; Sugio K; Hung J; Kishimoto Y; Virmani AK; Roa I; Albores-Saavedra J; Gazdar AF
Cancer Res; 1995 Jun; 55(12):2511-5. PubMed ID: 7780959
[TBL] [Abstract][Full Text] [Related]
9. Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.
Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
Anticancer Res; 2018 Oct; 38(10):5627-5634. PubMed ID: 30275180
[TBL] [Abstract][Full Text] [Related]
10. Adenosquamous/squamous cell carcinoma of the gallbladder.
Chan KM; Yu MC; Lee WC; Jan YY; Chen MF
J Surg Oncol; 2007 Feb; 95(2):129-34. PubMed ID: 17262729
[TBL] [Abstract][Full Text] [Related]
11. Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database.
Murimwa G; Hester C; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
J Gastrointest Surg; 2021 Jul; 25(7):1815-1827. PubMed ID: 32705618
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability in preneoplastic and neoplastic lesions of the gallbladder.
Roa JC; Roa I; Correa P; Vo Q; Araya JC; Villaseca M; Guzmán P; Schneider BG
J Gastroenterol; 2005 Jan; 40(1):79-86. PubMed ID: 15692793
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer Patients.
Gejman R; González S; Muñoz-Medel M; Nervi B; Sánchez C; Ibáñez C; Peña J; Madrid J; Briones J; Pérez P; Garrido M; Galindo H
Asian Pac J Cancer Prev; 2019 Jan; 20(1):1-4. PubMed ID: 30677862
[TBL] [Abstract][Full Text] [Related]
14. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
15. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of aggressive treatment of stage IV gallbladder cancer and predictors of survival.
Todoroki T; Takahashi H; Koike N; Kawamoto T; Kondo T; Yoshida S; Kashiwagi H; Otsuka M; Fukao K; Saida Y
Hepatogastroenterology; 1999; 46(28):2114-21. PubMed ID: 10521952
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
Rozenblum AB; Ilouze M; Dudnik E; Dvir A; Soussan-Gutman L; Geva S; Peled N
J Thorac Oncol; 2017 Feb; 12(2):258-268. PubMed ID: 27865871
[TBL] [Abstract][Full Text] [Related]
18. Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas.
Wang R; Pan Y; Li C; Zhang H; Garfield D; Li Y; Ye T; Hu H; Luo X; Li H; Zhang Y; Zhang J; Zhou X; Shen L; Pao W; Sun Y; Chen H
J Thorac Oncol; 2014 Jun; 9(6):760-8. PubMed ID: 24481316
[TBL] [Abstract][Full Text] [Related]
19. Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.
Yip PY; Yu B; Cooper WA; Selinger CI; Ng CC; Kennedy CW; Kohonen-Corish MR; McCaughan BC; Trent RJ; Boyer MJ; Kench JG; Horvath LG; O'Toole SA
J Thorac Oncol; 2013 Apr; 8(4):408-14. PubMed ID: 23392229
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder.
Yun SP; Shin N; Seo HI
World J Gastroenterol; 2015 Jan; 21(1):269-75. PubMed ID: 25574101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
